KOVALTRY

Bayer Inc🇨🇦 Health Canada

Approval Id: 28749a13d2b0f9e6
Drug Approval Canada Name: KOVALTRY
Product Name: KOVALTRY
Status: Marketed
Status Date: 2016-08-18
Original Market Date: 2016-08-18
Din: 02451492
Drug Class: Human
Dosage Form: Kit , Powder For Solution
Route Of Administration: Intravenous
Schedule: Schedule D
Ahfs: 20:28.16
Atc Original: B02BD02 COAGULATION FACTOR VIII
Atc Name: b 02 bd 02
Aig Number: 0124180007
Company Name: Bayer Inc
Company Address: 2920 Matheson Blvd East, Mississauga, Ontario, Canada, L4W 5R6

ANTIHEMOPHILIC FACTOR (RECOMBINANT)

3000 UNIT / VIAL

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

28749a13d2b0f9e6

Type

Standard